Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Cosentyx
Secukinumab 150mg
Powder for injection
Novartis New Zealand Limited
Novartis Pharma Stein AG, Stein, Switzerland
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Cosentyx
Secukinumab 150mg/mL
Solution for injection
Novartis New Zealand Limited
Novartis Pharma Stein AG, Stein, Switzerland
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Elonva
Corifollitropin alfa 0.2mg/mL
Solution for injection
Merck Sharp & Dohme (New Zealand) Limited
Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Elonva
Corifollitropin alfa 0.3mg/mL
Solution for injection
Merck Sharp & Dohme (New Zealand) Limited
Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
|
Dated this 21st day of April 2017.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz